Stand out for this role — generate a tailored resume and cover letter in about a minute.
AstraZeneca Oncology Research & Development is recruiting for the 2027 Baselga Cancer Research Scholars cohort. This 2-year immersive program is for early-career oncologists, offering mentorship, structured learning across clinical development, and rotations through cross-functional groups to build leadership and translational expertise.
You will participate in clinical study teams, design and oversee trial safety, and lead a longitudinal research project with opportunities to present at major
"It is critical that we build and maintain our rich tradition of clinical expertise in support of developing life-changing medicines for patients." –Jose Baselga
The Baselga Cancer Research Scholars Program, initiated in 2020, is a 2-year immersive education and research program for early-career Oncologists who are inspired by science and by how clinical development has the potential to transform patient care. As part of a competitively selected cohort of Scholars, you will join an accelerated development track within Oncology R&D. With individualized mentorship, there is opportunity to learn from a diverse group of experts across the drug development continuum, playing a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients’ lives. Selected Scholars will join the current cohort of Baselga Cancer Research Scholars, building a vibrant community of drug developers. We are currently recruiting for the 2027 class with an aim to start the position in summer‑autumn 2027.
Our Oncology strategy is built with one goal in mind – pushing the boundaries of science to deliver life-changing medicines to patients. We have a passion for discovery and a broad pipeline of next-generation medicines, and together with a focus on execution excellence, we aim to expand treatment options and improve outcomes for patients with solid and haematological cancers. We’re pioneering innovative research across six scientific platforms: Tumor drivers and resistance; Immuno-oncology, DNA damage response, Antibody drug conjugates, Epigenetics and Cell therapies. Our ambition is to eliminate cancer as a cause of death. It’s our big vision that unites and inspires us. With multiple indications and high-quality molecules at all stages of our innovative pipeline, we keep pushing forward. Focusing on cutting-edge science with the latest technology to achieve breakthroughs. AZ is a place built on courage, curiosity and collaboration – we make bold decisions driven by patient outcomes.
The 2027 AZ Baselga Cancer Research Scholars cohort will join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. Working in a fast-paced and dynamic work environment you will experience increasing levels of responsibility, following a structured learning plan in the following domains:
Specific duties and major responsibilities for the longitudinal medical project may include any of the following:
The annual base salary for this position ranges from $184,674.40 to $277,011. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an "at-will position" and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Complete your application before the below closing date. This role is open from 7th September, we welcome with your application no later than 16th October 2026.
Follow AstraZeneca on LinkedIn https://www.linkedin.com/company/1603/
Follow AstraZeneca on Facebook https://www.facebook.com/astrazenecacareers/
Follow AstraZeneca on Instagram https://www.instagram.com/astrazeneca_careers/?hl=en
09-Sept-2026
15-Oct-2026
Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.